Module 1: Endoscopy
Speaker slides here

Moderators: Gary A Neidich, MD, Sanford Children's Hospital and Jennifer Strople, MD, Ann & Robert H Lurie Children's Hospital

8:00am Management of Foreign Bodies
David Brumbaugh, MD, Children's Hospital Colorado
Objectives:   

1. Understand epidemiology, symptoms, and management of common gastrointestinal foreign body ingestions in children
2. Review new poison control guidelines for pre-hospital and in-hospital management of swallowed button batteries
3. Discuss clinical management of high-powered magnet ingestions

8:20am Advanced endoscopic techniques for gastrointestinal bleeding
Petar Mamula, MD, Children's Hospital of Philadelphia
Objectives:

1. Briefly discuss existing techniques for treatment of gastrointestinal (GI) bleeding
2. Discuss new techniques available for treatment of GI bleeding
3. Discuss endoscopy training in these techniques

8:40am  Cancer screening top to bottom
Srinadh Komanduri, MD, Northwestern Medicine
Objectives:

1. Recognize current recommendations for screening for CRC in specific populations and identify novel diagostic tools for screening
2. Understand the role of Barrett's Esophagus in development in Esophageal AdenoCA and the role of screening in GERD
3. Identify specific populations who need screening for pancreaticobiliary malignancies

Module 2: Potpourri

 Speaker slides here

Moderators: Terry Sigman, MD, FRCPC, Montreal Children's Hospital and Maria Oliva-Hemker, MD, Johns Hopkins University School of Medicine

9:00am Celiac disease: Beyond diagnosis
Alessio Fasano, MD, MassGeneral Hospital for Children
Objectives:

1. Review current celiac disease diagnostic criteria and critically review the need for an upper endoscopy to confirm diagnosis
2. Discuss the best approach to monitor compliance with the gluten free diet
3. Provide an overview of ongoing clinical trials aimed at identifying novel target for treatments alternative/complementary to the gluten free diet

9:20am The role of the gastroenterologist and hepatologist in Cystic Fibrosis (CF) Care today
Meghana Sathe, MD, UT Southwestern Medical Center
Objectives:

1. Understand the management of pancreatic replacement enzyme therapy
2. Become familiar with Cystic Fibrosis Transmembrane Recepetor (CFTR) Modulators and the potential impact on GI manifestation of CF
3. Recognize how to differentiate between Distal Intestinal Obstruction Syndrome (DIOS) and Constipation and understand variations in management

9:40am  Update on C. difficile
Sonia Michail, MD, Children's Hospital Los Angeles
Objectives:

1. Understand the manifestations and risks of development of clostridium difficile infection
2. Update on treatment of clostridium difficile infection
3. Understand options in difficult to treat cases

10:00am What the pediatric GI provider needs to know about cannabis
Ed Hoffenberg, MD, Children's Hospital Colorado
Objectives:

1. Describe how endocannabinoid system modulation may impact GI disorders
2. Identify complications and risks of cannabis use
3. Develop your own approach to discussing cannabis use with your patients

10:20am-10:40am Break     

Module 3: Functional/motility

 Speaker slides here

Moderators: Anil Darbari, MD, MBA, Children's National Medical Center and Maria Oliva-Hemker, MD, Johns Hopkins University School of Medicine

10:40am Testing for functional disorders: The indispensable, the useless, the dangerous
Carlo Di Lorenzo, MD, Nationwide Children's Hospital
Objectives:

1. When testing is needed in the child presenting with symptoms of IBS/FAP
2. Emphasize how to effectively provide reassurance in the office setting
3. Discuss the dangers and relevance of the incidental findings
4. Address conditions which may mimic pain predominant functional disorders

11:00am  Achalasia
Peter Kahrilas, MD, Northwestern Medicine
Objectives:

1. Review the sub-classification of achalasia and related syndromes
2. Understand the limitations pneumatic dilation and Heller myotomy in treating spastic achalasia (type III)
3. Appreciate the advantages and disadvantages of pneumatic dilation, per oral endoscopic myotomy (POEM) and laparoscopic Heller myotomy

11:20am Evaluation and treatment strategies in NERD and functional dyspepsia
Julie Khlevner, MD, Morgan Stanley Children's Hospital
Objectives:
1. Discuss the criteria for diagnosing NERD and functional dyspepsia
2. Understand the current concepts in pathogenesis of NERD and functional dyspepsia
3. Review evidence based approach to therapy in pediatric NERD and functional dyspepsia

Robert J. Shulman, MD, Children's Nutrition Research Center
Objectives:

1. Describe mechanisms whereby diet can induce symptoms
2. Enumerate pros and cons of different diets
3. Describe limitations of research on diet therapy

12:10pm-1:35pm Learning Lunches

1. Challenging celiac disease cases
   Moderator: Iona Monteiro, MD
   Alessio Fasano, MD, MassGeneral Hospital for Children and Maureen Leonard, MD, MassGeneral Hospital for Children
2. Comprehensive treatment of functional disorders—Difficult cases
   Moderator: Tanaz Danialifar, MD
   Carlo Di Lorenzo, MD, Nationwide Children's Hospital and Rob Shulman, MD, Children's Nutrition Research Center
3. Complicated IBD
   Moderator: Jeanne Tung, MD
   Anne Griffiths, MD, Hospital for Sick Children and David Rubin, MD, University of Chicago
4. Management of chronic cholestasis
   Moderator: Henry Lin, MD, MBA
   Saul Karpen, MD, PhD, Emory University and Sanjiv Harpavat, MD, PhD, Texas Children's Hospital
5. Chronic pancreatitis
   Moderator: Gary Galante, MD
   Sohail Husain, MD, Stanford Children's Hospital and Jaimie Nathan, MD, Cincinnati Children's Hospital Medical Center
6. NERD and Dyspepsia: Real world treatment
   Moderator: Kelly Fair Thomsen, MD, MSCI, CNSC
   Julie Khlevner, MD, Morgan Stanley Children's Hospital and Diana Lerner, MD,  Medical College of Wisconsin
7. Foreign body management in practice
   Moderator: Alex Koral, MD
   David Brumbaugh, MD, Children's Hospital Colorado and Petar Mamula, MD, Children's Hospital of Philadelphia
8. How to approach your patient who wants to use a medical marijuana product
   Moderator: Ellen Mitchell, MD
   Edward Hoffenberg, MD, Children's Hospital Colorado and Ann Ming Yeh, MD, Stanford University-Lucile Packard Children's Hospital
9. Eosinophilic GI disease
   Moderator: Garrett Zella, MD
   Edaire Cheng, MD, UT Southwestern Medical Center and Nathalie Nguyen, MD, Children’s Hospital Colorado

Module 4: Liver/Pancreas

  Speaker slides here

Moderators: Nadia Ovchinsky, MD, MBA, Children's Hospital at Montefiore and Jennifer Strople, MD, Ann & Robert H Lurie Children's Hospital

1:40pm New news in NAFLD
Miriam Vos, MD, MSPH, Emory University
Objectives:

1. Understand current concepts in pathogenesis
2. Update on diagnostic tools for NAFLD
3. Discuss clinical management of pediatric NAFLD

2:00pm New therapies for chronic cholestatic diseases
Saul J. Karpen, MD, PhD, Emory University School of Medicine/Children’s Healthcare of Atlanta
Objectives:

1. Know the array of new agents that target bile acid based hepatotoxicity of cholestatic diseases
2. Understand the approach to therapy for genetic forms of cholestatic diseases based upon specific genes and variants—chaperones and potentiators
3. Know the current status of the field regarding treatments for biliary atresia

2:20pm Diagnosing drug-induced pancreatitis
Sohail Husain, MD, Stanford Children's Hospital
Objectives:

1. Recognize the burden of drug-induced pancreatitis in children and the commonly associated drugs
2. Evaluate the causality indices for drug-induced pancreatitis
3. Review management guidelines for drug-induced pancreatitis in children

2:40pm  Pediatric pancreatic masses: Steroids, surgery or surveillance
Jaimie D. Nathan, MD, FACS, Cincinnati Children's Hospital Medical Center 
Objectives:

1. Recognize the presentation of pancreatic masses in children
2. Understand the workup and evaluation of pediatric pancreatic masses
3. Recognize the different etiologies and outcomes of pancreatic masses in children

3:00pm – 3:20pm  Break        

Module 5: Intestinal Inflammation

 Speaker slides here

Moderators: Deborah Neigut, MD, Children's Hospital Colorado and Jennifer Strople, MD, Ann & Robert H Lurie Children's Hospital
3:20pm Positioning the new IBD therapies: Merging experience with evidence
David T Rubin, MD, University of Chicago
Objectives:

1. Choose therapies based on prognosis and confirm effectiveness
2. Identify targets of treatment that are individualized based on patient symptoms and objective measures of disease activity
3. Understand risks and benefits of considering de-escalation and restart protocols in management

3:40pm Immunosuppressive therapy in IBD: Can we de-escalate therapy?
Anne Griffiths, MD, FRCPC, Hospital for Sick Children
Objectives:

1. Advise families concerning the likelihood of (and factors predictive of) successful discontinuation of biologic therapies
2. Utilize therapeutic drug monitoring to plan de-escalation of combination therapy with biologics
3. Initiate and utilize biologic therapies in a way most likely to allow long-term effectiveness while balancing risks

4:00pm  When it is not IBD…Rare forms of intestinal inflammation
Stacy Kahn, MD, Boston Children's Hospital
Objectives:

1. Learn to recognize and diagnose intestinal inflammation not due to IBD
2. Understand the natural history of a variety of rare forms of intestinal inflammation
3. Learn how to treat rare forms of intestinal inflammation

4:20pm  Eosinophilic inflammation beyond the esophagus
Edaire Cheng, MD, UT Southwestern Medical Center
Objectives:

1. Understanding the diagnostic criteria for eosinophilic gastrointestinal diseases (EGIDs)   
2. Recognizing clinical presentations for eosinophilic gastrointestinal diseases   
3. Understanding the relationship between EoE and EGIDs

Continuing Medical Education

NASPGHAN CME Mission Statement
The education mission of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition is to: 
1. Advance understanding of normal development, physiology and pathophysiology of diseases of the gastrointestinal tract, liver and nutrition in children
2. Improve professional competence, quality of care, and patient outcomes by disseminating knowledge through scientific meetings, professional and public education.
Our activities, education, and interventions will strive to use Adult Learning Methods (ALM) designed to improve competence, practice performance, and patient outcomes in measurable ways.  These educational activities will be targeted to board certified or board eligible pediatric gastroenterologists, physicians with an expertise in pediatric gastroenterology, hepatology and nutrition, subspecialty fellows in pediatric gastroenterology, and nurses specializing in pediatric gastroenterology, hepatology and nutrition.

Physicians
The North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA PRA Statement
NASPGHAN designates this live activity for a maximum of 8 AMA PRA Category 1 Credit(s)TM Physicians should only claim credit commensurate with the extent of their participation in the activity. 

Satisfactory Completion 
For MOC credit, learners must pass the post-test with a score of 60% or higher and complete an evaluation form to receive a certificate of completion. If you are seeking continuing education credit for a specialty not listed below, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.  

Nurses
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and NASPGHAN.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Amedco LLC designates this live activity for a maximum of 8 contact hours for nurses. Learners should claim only the credit commensurate with the extent of their participation in the activity. 

ABP MOC Part II Credits
Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn 8 MOC Part II points for the Postgraduate Course in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit. Participant must complete the assessment within 30 days of the activity. Participant information will be uploaded to ABP 30 days post activity.